Literature DB >> 16052691

Kinetics of phytohemaglutinin-induced IFN-gamma and TNF-alpha expression in peripheral blood mononuclear cells from patients with chronic hepatitis B after liver transplantation.

Ying-Mei Tang1, Min-Hu Chen, Gui-Hua Chen, Chang-Jie Cai, Xiao-Shun He, Min-Giang Lu, Wei-Min Bao.   

Abstract

AIM: To study the association between host immunity and hepatitis B virus (HBV) recurrence after liver transplantation.
METHODS: Peripheral blood mononuclear cells (PBMC) were isolated from 40 patients with hepatitis B and underwent orthotopic liver transplantation (OLT) before and 2, 4, 8 wk after surgery. After being cultured in vitro for 72 h, the levels of INF-gamma and TNF-alpha in culture supernatants were detected with ELISA. At the same time, the quantities of HBV DNA in serum and PBMCs were measured by real time PCR.
RESULTS: The levels of INF-gamma and TNF-alpha in PBMC culture supernatants decreased before and 2, 4 wk after surgery in turns (INF-gamma 155.52+/-72.32 ng/L vs 14.76+/-9.88 ng/L vs 13.22+/-10.35 ng/L, F = 6.946, P = 0.027 < 0.05; TNF-alpha 80.839+/-46.75 ng/L vs 18.59+/-17.29 ng/L vs 9.758+/-7.96 ng/L, F = 22.61, P = 0.0001 < 0.05). The levels of INF-gamma and TNF-alpha were higher in groups with phytohemagglutinin (PHA) than in those without PHA before surgery. However, the difference disappeared following OLT. Furthermore, INF-gamma and TNF-alpha could not be detected in most patients at wk 4 and none at wk 8 after OLT. The HBV detection rate and virus load in PBMC before and 2, 4 wk after surgery were fluctuated (HBV detected rate: 51.4%, 13.3%, 50% respectively; HBV DNA: 3.55+/-0.674 log10 copies/mL vs 3.00+/-0.329 log10 copies/mL vs 4.608+/-1.344 log10 copies/mL, F = 7.582, P = 0.002 < 0.05). HBV DNA in serum was 4.48+/-1.463 log10 copies/mL before surgery and <10(3) copies/mL after OLT except for one with 5.72 x 10(6) copies/mL 4 wk after OLT who was diagnosed as HBV recurrence. The levels of INF-gamma and TNF-alpha were lower in patients with a high HBV load than in those with a low HBV load (HBV DNA detected/undetected in PBMCs: IFN-gamma 138.08+/-72.44 ng/L vs 164.24+/-72.07 ng/L, t = 1.065, P = 0.297 > 0.05, TNF-alpha 80.75+/-47.30 ng/L vs 74.10+/-49.70 ng/L, t = 0.407, P = 0.686 > 0.05; HBV DNA positive/negative: IFN-gamma 136.77+/-70.04 ng/L vs 175.27+/-71.50 ng/L, t = 1.702, P = 0.097 > 0.05; TNF-alpha 75.37+/-43.02 ng/L vs 81.53+/-52.46 ng/L, t = 0.402, P = 0.690 > 0.05).
CONCLUSION: The yielding of INF-gamma and TNF-alpha from PBMCs is inhibited significantly by immunosuppressive agents following OLT with HBV load increased, indicating that the impaired immunity of host is associated with HBV recurrence after OLT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052691      PMCID: PMC4398711          DOI: 10.3748/wjg.v11.i29.4574

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

Review 1.  Incidence, timing, and risk factors for acute and chronic rejection.

Authors:  J Neuberger
Journal:  Liver Transpl Surg       Date:  1999-07

Review 2.  Recurrent hepatitis C after liver transplantation.

Authors:  R Teixeira; S Pastacaldi; G V Papatheodoridis; A K Burroughs
Journal:  J Med Virol       Date:  2000-08       Impact factor: 2.327

3.  Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity.

Authors:  Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
Journal:  J Med Virol       Date:  2004-11       Impact factor: 2.327

4.  Assessment of immunologic status of liver transplant recipients by peripheral blood mononuclear cells in response to stimulation by donor alloantigen.

Authors:  Y Chen; G J McKenna; E M Yoshida; A K Buczkowski; C H Scudamore; S R Erb; U P Steinbrecher; S W Chung
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

5.  Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms.

Authors:  G J Webster; S Reignat; M K Maini; S A Whalley; G S Ogg; A King; D Brown; P L Amlot; R Williams; D Vergani; G M Dusheiko; A Bertoletti
Journal:  Hepatology       Date:  2000-11       Impact factor: 17.425

6.  La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA.

Authors:  T Heise; L G Guidotti; F V Chisari
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

7.  Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection.

Authors:  A Brind; J Jiang; D Samuel; M Gigou; C Feray; C Bréchot; D Kremsdorf
Journal:  J Hepatol       Date:  1997-02       Impact factor: 25.083

8.  Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes.

Authors:  U Schultz; F V Chisari
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  Liver transplantation in China: problems and their solutions.

Authors:  Jian Wu; Shu-Sen Zheng
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2004-05

10.  Long-term follow-up of chronic hepatitis B patients treated with interferon alfa.

Authors:  A S Lok; H T Chung; V W Liu; O C Ma
Journal:  Gastroenterology       Date:  1993-12       Impact factor: 22.682

View more
  2 in total

1.  Impaired antigen processing and presentation machinery is associated with immunotolerant state in chronic hepatitis B virus infection.

Authors:  Sukriti Sukriti; Nirupma Trehan Pati; Sujoy Bose; Syed S Hissar; Shiv Kumar Sarin
Journal:  J Clin Immunol       Date:  2010-03-19       Impact factor: 8.317

2.  Probable involvement of p11 with interferon alpha induced depression.

Authors:  Jiqiang Guo; Wen Zhang; Lili Zhang; Huaxia Ding; Jingjing Zhang; Chen Song; Yanfei Zhang; Namei Xia; Mingfang Li; Yinming Liang; Xianzhang Hu; Haojiang Luan; Hui Wang
Journal:  Sci Rep       Date:  2016-01-29       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.